Showing 1 - 12 results of 12 for search 'M. Nijland', query time: 0.05s
Refine Results
-
1
Film transfer enabled by nanosheet seed layers on arbitrary sacrificial substrates by A. P. Dral, M. Nijland, G. Koster, J. E. ten Elshof
Published 2015-05-01
Article -
2
TMS-Induced Central Motor Conduction Time at the Non-Infarcted Hemisphere Is Associated with Spontaneous Motor Recovery of the Paretic Upper Limb after Severe Stroke by Maurits H. J. Hoonhorst, Rinske H. M. Nijland, Cornelis H. Emmelot, Boudewijn J. Kollen, Gert Kwakkel
Published 2021-05-01
Article -
3
-
4
-
5
P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL... by R. Cordoba, L. Falchi, T. Phillips, S. de Vos, M. Nijland, F. Offner, I. Bykhovski, J. Wu, L. Wang, A. Rana, P. Abrisqueta
Published 2022-06-01
Article -
6
Comparing two identically protocolized, multicentre, randomized controlled trials on caregiver-mediated exercises poststroke: Any differences across countries? by Marijn Mulder, Rinske H M Nijland, Judith D M Vloothuis, Maayken van den Berg, Maria Crotty, Gert Kwakkel, Erwin E H van Wegen
Published 2022-01-01
Article -
7
Comparing two identically protocolized, multicentre, randomized controlled trials on caregiver-mediated exercises poststroke: Any differences across countries? by Marijn Mulder, Rinske H. M. Nijland, Judith D. M. Vloothuis, Maayken van den Berg, Maria Crotty, Gert Kwakkel, Erwin E. H. van Wegen
Published 2022-01-01
Article -
8
P1135: SUBCUTANEOUS EPCORITAMAB IN COMBINATION WITH RITXUIMAB + LENALIDOMIDE IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PHASE 1/2 TRIAL UPDATE by D. Belada, S. Leppä, B. E. Wahlin, M. Nijland, J. H. Christensen, S. de Vos, H. Holte, K. M. Linton, A. Abbas, L. Wang, M. Dinh, B. Elliott, L. Falchi
Published 2022-06-01
Article -
9
Caregiver-mediated exercises with e-health support for early supported discharge after stroke (CARE4STROKE): A randomized controlled trial. by Judith D M Vloothuis, Marijn Mulder, Rinske H M Nijland, Quirine S Goedhart, Manin Konijnenbelt, Henry Mulder, Cees M P M Hertogh, Maurits van Tulder, Erwin E H van Wegen, Gert Kwakkel
Published 2019-01-01
Article -
10
P1254: RESPONSE TO DA-EPOCH-R IN PATIENTS WITH HIGH GRADE B CELL LYMPHOMA IS ASSOCIATED WITH A REDUCTION OF PD1 POSITIVE EXHAUSTED CD8 T CELLS by V. de Jonge, C. Duetz, W. Bruins, E. van Werkhoven, M. Nijland, K. de Heer, M. van der Poel, Y. Sandberg, C. Klerk, D. de Jong, J. Zijlstra, M. J. Kersten, T. Mutis, M. Chamuleau
Published 2022-06-01
Article -
11
P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY by J. Doorduijn, S. Issa, B. van der Holt, M. Minnema, T. Seute, M. Durian, G. Cull, M. van der Poel, W. Stevens, J. Zijlstra, M. Nijland, K. Mason, A. Beeker, D. Brandsma, M. van den Bent, M. Gonzalez, D. de Jong, J. Bromberg
Published 2022-06-01
Article -
12
P1209: INCIDENCE, TREATMENT AND OUTCOME OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: A POPULATION-BASED COHORT STUDY IN THE NETHERLANDS by F. O. Meeuwes, M. Brink, M. W. Van der Poel, M. J. Kersten, M. J. Wondergem, P. G. Mutsaers, L. H. Böhmer, F. J. S. H. Woei-A-Jin, O. Visser, R. Oostvogels, P. M. Jansen, W. J. Plattel, G. A. Huls, J. S. Vermaat, M. Nijland
Published 2022-06-01
Article